Micro-choice-based Intervention for Multicausal Fatigue
- Sponsor
- University Hospital, Basel, Switzerland
- Study ID
- NCT07726082
- Status
- Recruiting
Conditions
- Fatigue
- Long COVID Syndrome
- Multicausal Fatigue
- Post COVID Condition
- Postviral Fatigue
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - 65 Years
- Healthy Volunteers
- Not accepted
Interventions
- Micro-choice-based intervention — BEHAVIORALThe intervention consists of three phases: (1) a preparation phase including a preparatory webinar about the concept of micro-choices; active decision to participate; (2) a concentrated four-day group intervention based on the micro-choice model, delivered by an interdisciplinary team (psychosomatics, internal medicine, physiotherapy, occupational therapy); and (3) a follow-up phase over three weeks, during which participants are supported in integrating behavioral changes into everyday life through digital self-monitoring and an individual follow-up consultation
Study Details
This proof-of-concept study aims to evaluate the feasibility, acceptability, and potential benefits of a novel multimodal approach: the micro-choice-based intervention.
Key Dates
- First listed
- Jul 24, 2026
- Start date
- Aug 13, 2026
- Status verified
- Aug 2026
- Primary completion
- Aug 31, 2027
- Completion
- Aug 31, 2027
Study Design
- Enrollment
- 24 participants (estimated)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- TREATMENT
Arms
- Experimental: Intervention Arm
Primary Outcome Measure
Retention rate [ Time Frame: up to 6 month ]
Central Contacts
- Katrin Bopp, Dr.+41 61 265 50 05
Related Studies
- Behavioral and Neural Representations of Subjective Effort CostRecruiting · Hugo W. Moser Research Institute at Kennedy Krieger, Inc. · Baltimore, Maryland
- Sodium Bicarbonate and Mitochondrial Energetics in Persons With CKDPHASE2 · Recruiting · University of California, Davis · Sacramento, California
- Evaluating the Impact of Focused Muscle Contraction Therapy in U.S. VeteransRecruiting · University of Illinois at Chicago · Chicago, Illinois
- Combination Therapy for Treatment of Sleep Disturbance in Patients With Advanced CancerPHASE2/PHASE3 · Recruiting · M.D. Anderson Cancer Center · Houston, Texas